Orderliness and attention to individual details

Cancer, as we have pointed out, is a complex and multidimensional disease, and its nature is strongly determined by the patient's uniqueness. In order for the patient to reap the greatest possible benefit from any anti-cancer treatment procedure, both patients and physicians must respect and adapt to the complexity of the disease as well as its uniqueness. Unfortunately, the established oncological view faces the majority of cancer cases with the famous "protocols", which, despite the scientificity with which they are evaluated, remain only to have a statistical value. Dealing with "one size fits all" can deprive many patients the chance of a maximum successfully treatment.

Below we see the general approach to the cancer problem used in the individualized treatment context. Following this guide allows us to personalize the therapeutic effects to the maximum. Our patient must keep all the therapeutic possibilities open in all phases.

• Evaluation of the molecular biology of the tumor cell population
• Measurement of Cancer Circulating Cells
• Analysis of the living cells of the patient's tumor, to determine its sensitivities and potential for resistance to chemotherapy and other treatments
• Application of combinations of carcinogenic agents (targeted chemotherapy and adjuvant agents, radiotherapy, oncothermia, full body hyperthermia, immunotherapy, etc.)
• Inhibition of oncogenic expression
• Inhibition of neo-angiogenesis
• Inhibition of the enzyme 5-lipoxygenase (5-LOX) and cyclooxygenase (COX-1 & COX-2)
• Inhibition of cancer metastasis
• Maintaining bone integrity
• Correction of coagulation abnormalities

These formatted steps are very important, and perform better in patients who have not yet undergone toxic treatments. They can be done safely at the same time as conventional treatment. In newly diagnosed patients who have not yet been treated, the goal is to eliminate the primary tumor and metastatic cells with the "first multilevel therapeutic treatment" so that the circulating cells are not allowed to settle in the residual tumors. develop survival mechanisms that make them resistant to further treatments. The keys to this therapeutic approach are:

• Early therapeutic intervention, so that the body still maintains defense forces, and no metastases have been installed.
• Total and coordinated intervention, so that all the possibilities offered by current science are utilized.